Lyon Joseph Douglas's Form 4 filing
Corcept Therapeutics Inc (CORT) · filed Nov 3, 2023
- Accession no.
- 0000950170-23-058943
- Filed
- Nov 3, 2023
- Trade date
- Nov 1-2, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $140.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lyon Joseph DouglasCIK 0001817838 | Officer (Chief Accounting Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 1, 2023 | Common Stock | MOption exerciseAcquired | +1,023 | $11.35 | +$11,611.05 | 6,877 | Direct | |
| Nov 1, 2023 | Common Stock | SSaleDisposed | −1,023 | $28.08 | −$28,725.84 | 5,854 | Direct | |
| Nov 2, 2023 | Common Stock | MOption exerciseAcquired | +3,977 | $11.35 | +$45,138.95 | 9,831 | Direct | |
| Nov 2, 2023 | Common Stock | SSaleDisposed | −3,977 | $28.11F3 | −$111,793.47 | 5,854 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 1, 2023 | Common Stock | MOption exerciseDisposed | −1,023 | $0.00 | $0 | 53,144 | Direct | |
| Nov 2, 2023 | Common Stock | MOption exerciseDisposed | −3,977 | $0.00 | $0 | 49,167 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $28.08 to $28.1244. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.